Latest filing published 17 May 2023 for Charles River Laboratories International, INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
C. Richard Reese: trading record in brief
Filings by C. Richard Reese span 2 companies, the busiest being Charles River Laboratories International, Inc. and Iron Mountain Inc. In total, 63 filings cover trades dated from 15 December 2005 to 15 May 2023.
The open-market side counts 1 purchase for €5.6M alongside 14 sales for €16.3M. The net balance comes to €10.6M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 32 share grants and 8 option exercises.
The record was last updated on 17 May 2023 with a share grant in Charles River Laboratories International, Inc. The most recent open-market purchase was published on 16 August 2011, 5,563 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to C. Richard Reese
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 442 shares0Common StockSEC:0001127602-23-015854:1
- 664 shares0Common StockSEC:0001127602-23-015854:0
- 382 shares0Common StockSEC:0001127602-22-014444:1
- 575 shares0Common StockSEC:0001127602-22-014444:0
- 234 shares0Common StockSEC:0001127602-21-016115:1
- 355 shares0Common StockSEC:0001127602-21-016115:0
- 741 shares0Common StockSEC:0001127602-20-016240:0
- 487 shares0Common StockSEC:0001127602-20-016240:1
- 1,882 shares0Common StockSEC:0001127602-19-019736:0
- 619 shares0Common StockSEC:0001127602-19-019736:1
- 2,004 shares0Common StockSEC:0001127602-18-017515:0
- 699 shares0Common StockSEC:0001127602-18-017515:1
- 7,740 shares@ US$40.279.0% of flowCommon StockSEC:0001127602-17-034175:0
- 4,540 shares@ US$33.934.5% of flowCommon StockSEC:0001127602-17-034175:1
- 4,030 shares@ US$43.395.1% of flowCommon StockSEC:0001127602-17-034175:2
- 3,530 shares@ US$52.295.4% of flowCommon StockSEC:0001127602-17-034175:3
- 3,140 shares@ US$70.296.4% of flowCommon StockSEC:0001127602-17-034175:4
- 10,227 shares@ US$102.4030.4% of flowCommon StockSEC:0001127602-17-034175:5
- 864 shares0Common StockSEC:0001127602-17-018148:1
- 2,436 shares0Common StockSEC:0001127602-17-018148:0
- 10,710 shares@ US$30.4410.5% of flowCommon StockSEC:0001127602-16-068550:0
- 551 shares@ US$71.921.3% of flowCommon StockSEC:0001127602-16-068550:1
- 3,988 shares@ US$71.939.3% of flowCommon StockSEC:0001127602-16-068550:2
- 2,260 shares0Common StockSEC:0001127602-16-052265:0
- 850 shares0Common StockSEC:0001127602-16-052265:1
25 of 62 declarations